cycloserine has been researched along with Depression in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (30.43) | 18.7374 |
| 1990's | 2 (8.70) | 18.2507 |
| 2000's | 3 (13.04) | 29.6817 |
| 2010's | 9 (39.13) | 24.3611 |
| 2020's | 2 (8.70) | 2.80 |
| Authors | Studies |
|---|---|
| Arora, PR; Ashavaid, TF; Blum, AJ; Gajjar, I; Gupta, A; Gupte, N; Karane, M; Kharat, N; Mullerpattan, JB; Pinto, LM; Rodrigues, C; Sawant, N; Sharma, S; Shivakumar, SVBY; Tornheim, JA; Udwadia, ZF | 1 |
| Intini, E; Kishore, G; Richeldi, L; Udwadia, ZF | 1 |
| Centner, CM; Chirehwa, M; Court, R; de Vries, N; Denti, P; Gumbo, T; Harding, J; Maartens, G; McIlleron, H; Wiesner, L | 1 |
| Altemus, M; Cukor, J; Difede, J; Lee, FS; Olden, M; Peskin, M; Wyka, K | 1 |
| Bhatt, JM; Dravid, SM; Gupta, SC; Hillman, BG; Pavuluri, R; Stairs, DJ; Suryavanshi, P; Yadav, R | 1 |
| Altemus, M; Cukor, J; Difede, J; Hoffman, H; Lee, FS; Olden, M; Wyka, K | 1 |
| Adongo, DW; Ameyaw, EO; Kukuia, KK; Mante, PK; Woode, E | 1 |
| Altemus, M; Cukor, J; Difede, J; Finkelstein-Fox, L; Lee, FS; Olden, M; Peskin, M; Rabinowitz, T; Wyka, K | 1 |
| Anker, J; Grant, JE; Kim, SW; Kushner, MG; Yoon, G | 1 |
| Dubrovina, NI; Zinovyev, DR; Zinovyeva, DV | 1 |
| Dubrovina, NI; Zinov'eva, DV | 1 |
| Dubrovina, NI | 1 |
| WAARDENBURG, HA | 1 |
| REZNIK, SE; VILDERMAN, AM | 1 |
| RYSANEK, K; VITEK, V; VOJTECHOVSKY, M | 1 |
| Leung, JS | 1 |
| Chau, CH; Lee, J; Wong, CF; Wong, PC; Yew, WW | 1 |
| Boje, KM; Lopes, T; Neubauer, P | 1 |
| Amico, E; Evins, AE; Goff, DC; Posever, TA; Toker, R | 1 |
| Byrd, RB; Gracey, DR; Kaplan, PD | 1 |
| Lester, W; Mitchell, RS | 1 |
| Biondi, L; Pasargiklian, M | 1 |
| Dissmann, E | 1 |
1 review(s) available for cycloserine and Depression
| Article | Year |
|---|---|
Clinical experience with cycloserine in the treatment of tuberculosis.
Topics: Brain; Cycloserine; Depression; Humans; Psychoses, Substance-Induced; Seizures; Time Factors; Tuberculosis | 1970 |
4 trial(s) available for cycloserine and Depression
| Article | Year |
|---|---|
The relationship between posttraumatic and depressive symptoms during virtual reality exposure therapy with a cognitive enhancer.
Topics: Adolescent; Adult; Aged; Cognition; Cycloserine; Depression; Female; Humans; Implosive Therapy; Male; Middle Aged; Nootropic Agents; Psychiatric Status Rating Scales; Stress Disorders, Post-Traumatic; Survivors; Treatment Outcome; Virtual Reality Exposure Therapy; Young Adult | 2019 |
D-cycloserine augmentation of exposure therapy for post-traumatic stress disorder: a pilot randomized clinical trial.
Topics: Adult; Aged; Anger; Chemotherapy, Adjuvant; Chronic Disease; Cycloserine; Depression; Double-Blind Method; Extinction, Psychological; Fear; Female; Humans; Implosive Therapy; Male; Middle Aged; Pilot Projects; Psychiatric Status Rating Scales; Psychotropic Drugs; Sleep; Stress Disorders, Post-Traumatic; Time Factors; Treatment Outcome | 2014 |
Pilot Study of a Telehealth-Delivered Medication-Augmented Exposure Therapy Protocol for PTSD.
Topics: Adult; Combined Modality Therapy; Cycloserine; Depression; Female; Humans; Implosive Therapy; Male; Middle Aged; Patient Satisfaction; Pilot Projects; Remote Consultation; Stress Disorders, Post-Traumatic; Treatment Outcome; Young Adult | 2017 |
D-Cycloserine added to risperidone in patients with primary negative symptoms of schizophrenia.
Topics: Adult; Antipsychotic Agents; Cycloserine; Depression; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Psychiatric Status Rating Scales; Risperidone; Schizophrenia; Schizophrenic Psychology; Treatment Outcome | 2002 |
18 other study(ies) available for cycloserine and Depression
| Article | Year |
|---|---|
Cycloserine did not increase depression incidence or severity at standard dosing for multidrug-resistant tuberculosis.
Topics: Antitubercular Agents; Cycloserine; Depression; Humans; Incidence; Tuberculosis, Multidrug-Resistant | 2022 |
Neuropsychiatric reactions induced by cycloserine in the treatment of multidrug-resistant tuberculosis: what an Indian female patient tells us.
Topics: Antitubercular Agents; Cycloserine; Depression; Female; Humans; India; Middle Aged; Suicide, Attempted; Tuberculosis, Multidrug-Resistant | 2019 |
Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis.
Topics: Adult; Antibiotics, Antitubercular; Cycloserine; Depression; Female; HIV Infections; Humans; Incidence; Isoxazoles; Male; Middle Aged; Oxazolidinones; Peripheral Nervous System Diseases; Prospective Studies; Psychoses, Substance-Induced; Risk Factors; Tuberculosis, Multidrug-Resistant | 2021 |
Deletion of glutamate delta-1 receptor in mouse leads to enhanced working memory and deficit in fear conditioning.
Topics: Amygdala; Animals; Behavior, Animal; Conditioning, Psychological; Cues; Cycloserine; Depression; Disks Large Homolog 4 Protein; Emotions; Fear; Gene Expression Regulation; Glutamate Decarboxylase; Glutamate Dehydrogenase; Guanylate Kinases; Hippocampus; Maze Learning; Membrane Proteins; Memory, Short-Term; Mice; Mice, Knockout; Prefrontal Cortex; Protein Isoforms; Receptors, Glutamate | 2013 |
Antidepressant-Like Effect of the Leaves of Pseudospondias microcarpa in Mice: Evidence for the Involvement of the Serotoninergic System, NMDA Receptor Complex, and Nitric Oxide Pathway.
Topics: Anacardiaceae; Animals; Antidepressive Agents; Cycloserine; Depression; Humans; Mice; Nitric Oxide; Plant Extracts; Plant Leaves; Receptors, N-Methyl-D-Aspartate; Serotonergic Neurons; Signal Transduction | 2015 |
Low-Dose d-Cycloserine for Depression?
Topics: Cycloserine; Depression; Depressive Disorder; Humans; Psychiatric Status Rating Scales; Receptors, N-Methyl-D-Aspartate | 2016 |
N-methyl-D-aspartate receptors and amnesia in mice with depression-like state.
Topics: Amnesia; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Cycloserine; Depression; Dizocilpine Maleate; Excitatory Amino Acid Agonists; Excitatory Amino Acid Antagonists; Kynurenic Acid; Male; Mice; Mice, Inbred C57BL; N-Methylaspartate; Receptors, Amino Acid | 2007 |
[Interaction of N-methyl-D-aspartate and Dopamine D1 receptors in modulation of passive avoidance extinction at mice with depressive-like state].
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Avoidance Learning; Cycloserine; Depression; Depressive Disorder; Dopamine; Dopamine Agonists; Extinction, Psychological; Injections, Intraperitoneal; Male; Memory; Mice; Mice, Inbred C57BL; Models, Animal; N-Methylaspartate; Receptor Cross-Talk; Receptors, Dopamine D1; Receptors, N-Methyl-D-Aspartate | 2011 |
[Fear memory extinction accelerated by simultaneous activation of GABA(B) and NMDA receptors].
Topics: Animals; Antimetabolites; Avoidance Learning; Baclofen; Cycloserine; Depression; Extinction, Psychological; Fear; GABA-B Receptor Agonists; Male; Memory; Mice; Mice, Inbred C57BL; Receptors, GABA-B; Receptors, N-Methyl-D-Aspartate | 2012 |
[SUICIDE AFTER PROLONGED USE OF CYCLOSERINE].
Topics: Cycloserine; Depression; Depressive Disorder; Ethionamide; Isoniazid; Pyridoxine; Suicide; Toxicology; Tuberculosis; Tuberculosis, Pulmonary | 1964 |
[USE OF PYRIDOXINE IN THE TREATMENT OF SIDE EFFECTS OF ANTITUBERCULAR AGENTS].
Topics: Antitubercular Agents; Cycloserine; Depression; Drug Therapy; Eye Manifestations; Isoniazid; Paresthesia; Pyridoxine; Streptomycin; Toxicology; Tuberculosis; Tuberculosis, Pulmonary; Vertigo | 1963 |
[HUMORAL FACTORS IN THE ETIOLOGY OF DEPRESSION FOLLOWING TREATMENT WITH RAUWOLFIA ALKALOIDS AND IN ALCOHOLICS].
Topics: Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Alcoholics; Alcoholism; Alcohols; Antineoplastic Agents; Cycloserine; Depression; Ethanol; Hydroxyindoleacetic Acid; Norepinephrine; Rabbits; Rauwolfia; Research; Secologanin Tryptamine Alkaloids; Serotonin; Toxicology; Uracil | 1964 |
Suicides in general hospitals.
Topics: Adrenergic beta-Antagonists; Analgesics; Anti-Infective Agents, Urinary; Antipsychotic Agents; Clonidine; Cycloserine; Depression; Hospitals, General; Humans; Inpatients; Reserpine; Suicide | 2004 |
Adverse neurological reactions in patients with multidrug-resistant pulmonary tuberculosis after coadministration of cycloserine and ofloxacin.
Topics: Adult; Cycloserine; Depression; Drug Therapy, Combination; Humans; Male; Middle Aged; Ofloxacin; Seizures; Sleep Initiation and Maintenance Disorders; Tuberculosis, Multidrug-Resistant; Tuberculosis, Pulmonary | 1993 |
Chronic administration of NMDA glycine partial agonists induces tolerance in the Porsolt swim test.
Topics: Animals; Antidepressive Agents, Tricyclic; Antimetabolites; Cycloserine; Depression; Dose-Response Relationship, Drug; Glycine Agents; Imipramine; Male; Rats; Rats, Sprague-Dawley; Receptors, N-Methyl-D-Aspartate; Stress, Psychological; Swimming | 1997 |
Treatment of pulmonary tuberculosis.
Topics: Capreomycin; Cells, Cultured; Chemical and Drug Induced Liver Injury; Cycloserine; Depression; Drug Hypersensitivity; Drug Resistance, Microbial; Drug Therapy, Combination; Ethambutol; Follow-Up Studies; Hospitalization; Humans; Isoniazid; Kanamycin; Kidney Diseases; Optic Neuritis; Patient Education as Topic; Rifampin; Streptomycin; Tuberculosis, Pulmonary | 1974 |
Neurologic and behavioural reactions of tuberculous patients treated with cycloserine.
Topics: Anxiety; Behavior; Cycloserine; Depression; Electroencephalography; Humans; Neurologic Manifestations; Tuberculosis | 1970 |
Experience with cycloserine.
Topics: Cycloserine; Depression; Drug Resistance, Microbial; Ethionamide; Humans; Pyrazinamide; Tetany; Tuberculosis, Pulmonary | 1970 |